Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982059 · ClinicalTrials.gov registry record
Colorectal Cancer Screening for Cancer Survivors
A clinical trial, sponsored by University Health Network, Toronto.
- Completed
- Registry status
- 140
- Enrollment target
NCT00982059 is a clinical trial that has completed, run by University Health Network, Toronto. The registered enrollment target is 140 participants.
The verdict
NCT00982059 has completed, sponsored by University Health Network, Toronto.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
The risk of colorectal cancer (CRC) is significant among cancer survivors treated with abdominal radiation therapy (RT). Further, CRC is once of the few cancers for which there is effective screening. Although some expert groups recommend early CRC screening for patients with prior abdominal RT, the effectiveness of early screening is unknown. It is also unknown if radiation-induced CRC passes through a "pre-clinical" phase in which precancerous polyps are detectable and treatable prior to becoming invasive cancers. This study will evaluate whether screening will detect pre-invasive colorectal polyps among survivors treated with RT.
Interventions
- OTHER Colonoscopic examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2008-05 |
| Est. Completion | 2018-01-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00982059
The ClinicalTrials.gov registry entry for NCT00982059 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Health Network, Toronto, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Colonoscopic examination is the first listed.
NCT00982059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00982059 about?
NCT00982059 is a clinical study titled "Colorectal Cancer Screening for Cancer Survivors". The risk of colorectal cancer (CRC) is significant among cancer survivors treated with abdominal radiation therapy (RT). Further, CRC is once of the few cancers for which there is effective screening. Although some expert groups recommend early CRC screening for patients with prior abdominal RT, the...
What is the current status of trial NCT00982059?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2008-05. Estimated completion is 2018-01-24.
What interventions are being tested in trial NCT00982059?
The interventions under investigation include: Colonoscopic examination (OTHER).
Who is sponsoring clinical trial NCT00982059?
This trial is sponsored by University Health Network, Toronto, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.